Bluejay Diagnostics, Inc. Common Stock
Symbol: BJDX (NASDAQ)
1.95
▲ (8.66%) 0.155
Company Description:
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
Key Stats
- Today's Open: $1.78
- Today's High: $1.99
- Today's Low: $1.725
- Today's Volume: 110.55K
- Yesterday Close: $1.79
- Yesterday High: $1.86
- Yesterday Low: $1.72
- Yesterday Volume: 33.48K
- Last Min Volume: 17
- Last Min High: $1.945
- Last Min Low: $1.945
- Last Min VWAP: $1.945
Company Profile
- Name: Bluejay Diagnostics, Inc. Common Stock
- Website: https://www.bluejaydx.com
- Listed Date: 2021-11-10
- Location: ACTON, MA
- Market Status: Active
- CIK Number: 0001704287
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $2.66M
- Round Lot: 100
- Outstanding Shares: 1.49M
- Asset Type: CS
RECENT FILINGS FOR BJDX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-05-16 | DEF 14A | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-08 | 424B3 | View |
| 2025-05-07 | EFFECT | View |
| 2025-05-06 | PRE 14A | View |
| 2025-04-29 | S-3 | View |
| 2025-04-29 | 10-K/A | View |
| 2025-04-09 | 8-K | View |
| 2025-03-31 | 10-K | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
| 2025-01-03 | SCHEDULE 13G/A | View |
| 2024-12-04 | 8-K | View |
| 2024-11-18 | 8-K | View |
| 2024-11-14 | SC 13G | View |
| 2024-11-14 | SC 13G/A | View |
| 2024-11-07 | 10-Q | View |
| 2024-10-24 | 8-K | View |
| 2024-10-16 | DEFA14A | View |
| 2024-10-16 | 8-K | View |
Latest News on BJDX